Literature DB >> 33776943

Pituitary Disorders and COVID-19, Reimagining Care: The Pandemic A Year and Counting.

Maria Fleseriu1.   

Abstract

Entities:  

Keywords:  COVID–19; SARS–CoV–2; medical treatment; pituitary; risk

Mesh：

Year:  2021        PMID： 33776943      PMCID： PMC7996050          DOI： 10.3389/fendo.2021.656025

Source DB:  PubMed          Journal:  Front Endocrinol (Lausanne)        ISSN： 1664-2392            Impact factor:   5.555


× No keyword cloud information.
  53 in total

1.  Successful management of a patient with active Cushing's disease complicated with coronavirus disease 2019 (COVID-19) pneumonia.

Authors:  Akiko Yuno; Yoshiyuki Kenmotsu; Yuka Takahashi; Hiroshi Nomoto; Hiraku Kameda; Kyu Yong Cho; Akinobu Nakamura; Yu Yamashita; Junichi Nakamura; Sho Nakakubo; Keisuke Kamada; Masaru Suzuki; Hirokazu Sugino; Naoko Inoshita; Satoshi Konno; Hideaki Miyoshi; Tatsuya Atsumi; Yutaka Sawamura; Akira Shimatsu
Journal:  Endocr J       Date:  2020-12-24       Impact factor: 2.349

Review 2.  Pituitary Diseases and Bone.

Authors:  Gherardo Mazziotti; Stefano Frara; Andrea Giustina
Journal:  Endocr Rev       Date:  2018-08-01       Impact factor: 19.871

Review 3.  Acromegalic osteopathy.

Authors:  G Mazziotti; F Maffezzoni; S Frara; A Giustina
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

4.  Letter to the Editor: "Our Response to COVID-19 as Endocrinologists and Diabetologists".

Authors:  Leandro Kasuki; Mônica R Gadelha
Journal:  J Clin Endocrinol Metab       Date:  2020-07-01       Impact factor: 5.958

5.  A Pituitary Society update to acromegaly management guidelines.

Authors:  Maria Fleseriu; Beverly M K Biller; Pamela U Freda; Monica R Gadelha; Andrea Giustina; Laurence Katznelson; Mark E Molitch; Susan L Samson; Christian J Strasburger; A J van der Lely; Shlomo Melmed
Journal:  Pituitary       Date:  2020-10-20       Impact factor: 4.107

6.  The direct and indirect impact of the COVID-19 pandemic on the care of patients with pituitary disease: a cross sectional study.

Authors:  Anneke Graf; Hani J Marcus; Stephanie E Baldeweg
Journal:  Pituitary       Date:  2020-11-24       Impact factor: 4.107

7.  Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study.

Authors:  Sufei Wang; Pei Ma; Shujing Zhang; Siwei Song; Zhihui Wang; Yanling Ma; Juanjuan Xu; Feng Wu; Limin Duan; Zhengrong Yin; Huilin Luo; Nian Xiong; Man Xu; Tianshu Zeng; Yang Jin
Journal:  Diabetologia       Date:  2020-07-10       Impact factor: 10.122

Review 8.  COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency.

Authors:  A M Isidori; G Arnaldi; M Boscaro; A Falorni; C Giordano; R Giordano; R Pivonello; R Pofi; V Hasenmajer; M A Venneri; E Sbardella; C Simeoli; C Scaroni; A Lenzi
Journal:  J Endocrinol Invest       Date:  2020-04-25       Impact factor: 4.256

9.  Dexamethasone in Hospitalized Patients with Covid-19.

Authors:  Peter Horby; Wei Shen Lim; Jonathan R Emberson; Marion Mafham; Jennifer L Bell; Louise Linsell; Natalie Staplin; Christopher Brightling; Andrew Ustianowski; Einas Elmahi; Benjamin Prudon; Christopher Green; Timothy Felton; David Chadwick; Kanchan Rege; Christopher Fegan; Lucy C Chappell; Saul N Faust; Thomas Jaki; Katie Jeffery; Alan Montgomery; Kathryn Rowan; Edmund Juszczak; J Kenneth Baillie; Richard Haynes; Martin J Landray
Journal:  N Engl J Med       Date:  2020-07-17       Impact factor: 91.245

10.  ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of Cushing's syndrome.

Authors:  John Newell-Price; Lynnette K Nieman; Martin Reincke; Antoine Tabarin
Journal:  Eur J Endocrinol       Date:  2020-07       Impact factor: 6.558
View more
  4 in total

Review 1.  Successful Immunomodulatory Treatment of COVID-19 in a Patient With Severe ACTH-Dependent Cushing's Syndrome: A Case Report and Review of Literature.

Authors:  Bojana Popovic; Aleksandra Radovanovic Spurnic; Jelena Velickovic; Aleksandra Plavsic; Milica Jecmenica-Lukic; Tijana Glisic; Dusan Ilic; Danka Jeremic; Jelena Vratonjic; Vladimir Samardzic; Zoran Gluvic; Tatjana Adzic-Vukicevic
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-22       Impact factor: 6.055

2.  Optic neuritis concomitant with pituitary macroadenoma in a patient with active COVID-19 infection: A case report.

Authors:  Mohammed Maan Al-Salihi; Md Moshiur Rahman; Maryam Sabah Al-Jebur; Sabrina Rahman; Ivan David Lozada-Martinez; Raphia Rahman; Luis Rafael Moscote-Salazar
Journal:  Int J Surg Open       Date:  2021-08-25

Review 3.  COVID-19 and hypopituitarism.

Authors:  Stefano Frara; Paola Loli; Agnese Allora; Chiara Santini; Luigi di Filippo; Pietro Mortini; Maria Fleseriu; Andrea Giustina
Journal:  Rev Endocr Metab Disord       Date:  2021-08-13       Impact factor: 9.306

Review 4.  Treatment of Cushing's syndrome with osilodrostat: practical applications of recent studies with case examples.

Authors:  Maria Fleseriu; Beverly M K Biller
Journal:  Pituitary       Date:  2022-08-24       Impact factor: 3.599
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.